Exiris Exiris
  • About Us
    • Company Profile
    • Management Team
    • Team
    • Board of Directors
    • Scientific Advisors
    • Publications & Patents
  • Technologies
    • Antibody ID
    • Drug Conjugates
    • Cancer Stem Cell
  • Drug Discovery Pipeline
  • Services
    • Platform Technologies
    • Biomarker Discovery
    • Human Skin Equivalents
    • Drug Development Services
  • News
  • Contacts
    • Job Opportunities
Exiris Exiris
  • About Us
    • Company Profile
    • Management Team
    • Team
    • Board of Directors
    • Scientific Advisors
    • Publications & Patents
  • Technologies
    • Antibody ID
    • Drug Conjugates
    • Cancer Stem Cell
  • Drug Discovery Pipeline
  • Services
    • Platform Technologies
    • Biomarker Discovery
    • Human Skin Equivalents
    • Drug Development Services
  • News
  • Contacts
    • Job Opportunities
Feb 18

Exiris @ RaiNews24

  • 18th February 2021
  • News

RaiNews24, the national TV channel reporting on Italian news, interviews Gessica Filocamo, Exiris Director of Biology Labs, on their pharmaceutical research, as part of the research community of biotech companies homed at the “Polo Biotecnologico di Castel Romano”.

https://www.exiris.it/exiris/wp/wp-content/uploads/2021/02/exiris.mp4

(source & copyright: https://www.rainews.it/dl/rainews/media/Il-Lazio-nella-corsa-al-vaccino-anti-Covid-d5c7eea1-e334-4d51-9756-e75e48ce6bea.html)

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • E-Mail

Comments are closed.

Latest News

  • Exiris a Maker Faire Roma 2024
  • “EVEarlyPannel: Tumor Screening 2.0”
  • Interview with Paola Gallinari on “Osservatorio medico-scientifico”
  • Exiris @ RaiNews24
  • Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019
  • Exiris receives European Union research grant for the ETN MAGICBULLET RELOADED project
  • New data presented at the 35th European Peptide Symposium, 35EPS, Dublin 26th-31st August 2018
  • New data presented at the Peptides and Conjugates for Tumor Targeting, Therapy and Diagnosis, Riminipeptide2018 Congress
  • Exiris is awarded a grant from Regione Lazio LIFE 2020
  • Exiris files patent application on novel cancer therapeutic antibodies
© 2016 Exiris Srl · P.IVA 10897561006